Pages that link to "Q35855143"
Jump to navigation
Jump to search
The following pages link to DNA vaccines to attack cancer (Q35855143):
Displaying 50 items.
- Prime-boost vaccination with plasmid and adenovirus gene vaccines control HER2/neu+ metastatic breast cancer in mice (Q24813328) (← links)
- In vivo electroporation enhances the immunogenicity of an HIV-1 DNA vaccine candidate in healthy volunteers (Q28744555) (← links)
- Topical vaccination: the skin as a unique portal to adaptive immune responses (Q33290410) (← links)
- DNA vaccines: developing new strategies against cancer (Q33756622) (← links)
- Anti-tumor effects of a human VEGFR-2-based DNA vaccine in mouse models (Q35575231) (← links)
- Superior Immunologic and Therapeutic Efficacy of a Xenogeneic Genetic Cancer Vaccine Targeting Carcinoembryonic Human Antigen. (Q35822301) (← links)
- Idiotypic DNA vaccination for the treatment of multiple myeloma: safety and immunogenicity in a phase I clinical study (Q35863376) (← links)
- Vaccinology at the beginning of the 21st century (Q36159950) (← links)
- Plasmid DNA vaccines against cancer: cytotoxic T-lymphocyte induction against tumor antigens (Q36198661) (← links)
- Immunotherapy in multiple myeloma--possibility or probability? (Q36206601) (← links)
- The rational design of vaccines (Q36300601) (← links)
- Strategies for DNA vaccine delivery (Q36316818) (← links)
- The rationale for prophylactic cancer vaccines and need for a paradigm shift (Q36423899) (← links)
- PSA-based vaccines for the treatment of prostate cancer (Q36445536) (← links)
- Human major histocompatibility complex (MHC) class I molecules with disulfide traps secure disease-related antigenic peptides and exclude competitor peptides (Q36512035) (← links)
- The role of peptide and DNA vaccines in myeloid leukemia immunotherapy (Q36608571) (← links)
- NY-ESO-1 immunotherapy for multiple myeloma (Q36637651) (← links)
- Hepatitis B virus core antigen as a carrier for Chlamydia trachomatis MOMP multi-epitope peptide enhances protection against genital chlamydial infection (Q36685400) (← links)
- Plasmid-based gene therapy of diabetes mellitus (Q36704473) (← links)
- Cancer vaccines: Looking to the future (Q36866158) (← links)
- Immunodeficiency and immunotherapy in multiple myeloma (Q36904977) (← links)
- Plasmid DNA and viral vector-based vaccines for the treatment of cancer (Q36909996) (← links)
- DNA vaccines: precision tools for activating effective immunity against cancer. (Q37064852) (← links)
- A plant-expressed conjugate vaccine breaks CD4(+) tolerance and induces potent immunity against metastatic Her2(+) breast cancer (Q37078963) (← links)
- Antibody-peptide-MHC fusion conjugates target non-cognate T cells to kill tumour cells (Q37407181) (← links)
- Synthetic vehicles for DNA vaccination (Q37611034) (← links)
- Humoral immunotherapy of multiple myeloma: perspectives and perplexities. (Q37724368) (← links)
- TAA polyepitope DNA-based vaccines: a potential tool for cancer therapy (Q37771268) (← links)
- Hepatitis B virus surface antigen as delivery vector can enhance Chlamydia trachomatis MOMP multi-epitope immune response in mice (Q37845082) (← links)
- DNA fusion vaccines enter the clinic. (Q37885288) (← links)
- Xenogene vaccination in the therapy of cancer (Q38229368) (← links)
- Cancer vaccine adjuvants--recent clinical progress and future perspectives (Q38260496) (← links)
- Immunotherapeutic approaches for cancer therapy: An updated review (Q38388102) (← links)
- Trans-sialidase from Trypanosoma brucei as a potential target for DNA vaccine development against African trypanosomiasis (Q39463391) (← links)
- DNA/amphiphilic block copolymer nanospheres promote low-dose DNA vaccination (Q39509643) (← links)
- Enhancement of DNA vaccine efficacy by targeting the xenogeneic human chorionic gonadotropin, survivin and vascular endothelial growth factor receptor 2 combined tumor antigen to the major histocompatibility complex class II pathway (Q39637966) (← links)
- Construction of a triple modified p53 containing DNA vaccine to enhance processing and presentation of the p53 antigen (Q39781285) (← links)
- Targeting anti-tumor DNA vaccines to dendritic cells via a short CD11c promoter sequence (Q39823580) (← links)
- Multiepitope peptide-loaded virus-like particles as a vaccine against hepatitis B virus-related hepatocellular carcinoma (Q39885468) (← links)
- Vaccination with liposome--DNA complexes elicits enhanced antitumor immunity (Q40255867) (← links)
- Induction of Homologous Rather than Heterologous Antigen-Specific CD4 T Cell Responses Is Critical for Functional CD8 T Cell Responses in Mice Transgenic for a Foreign Antigen (Q42879333) (← links)
- DNA fusion gene vaccination mobilizes effective anti-leukemic cytotoxic T lymphocytes from a tolerized repertoire (Q42949404) (← links)
- Suppression of breast tumor growth by DNA vaccination against phosphatase of regenerating liver 3. (Q43522873) (← links)
- The role of gamma interferon in DNA vaccine-induced tumor immunity targeting simian virus 40 large tumor antigen (Q45355231) (← links)
- Linked CD4 T Cell Help: Broadening Immune Attack Against Cancer by Vaccination (Q49013708) (← links)
- Linear doggybone DNA vaccine induces similar immunological responses to conventional plasmid DNA independently of immune recognition by TLR9 in a pre-clinical model. (Q50058150) (← links)
- Optimizing cancer immunotherapy trials: back to basics. (Q53625750) (← links)
- Targeting Head and Neck Cancer by Vaccination. (Q54217605) (← links)
- Immune strategies using single-component LipL32 and multi-component recombinant LipL32-41-OmpL1 vaccines against leptospira. (Q54470978) (← links)
- Engineered biomaterials for development of nucleic acid vaccines (Q59412972) (← links)